Revelation Biosciences, Inc. (REVB)

NASDAQ: REVB · Real-Time Price · USD

1.280

-0.060 (-4.48%)

At close: Oct 29, 2025, 4:00 PM EDT

1.300

+0.020 (1.55%)

After-hours: Oct 29, 2025, 7:53 PM EDT

Revelation Biosciences Employees

Revelation Biosciences had 9 employees as of December 31, 2024. The number of employees decreased by 1 or -10.00% compared to the previous year.

Employees

9

Change (1Y)

-1

Growth (1Y)

-10.00%

Revenue / Employee

n/a

Profits / Employee

-$1,293,837

Market Cap

2.99M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	9	-1	-10.00%
Dec 31, 2023	10	4	66.67%
Dec 31, 2022	6	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

REVB News

17 hours ago - Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date - Accesswire
14 days ago - Revelation Biosciences Inc. Announces Adjournment of October 15, 2025 Special Meeting of Stockholders to October 29, 2025 - Accesswire
6 weeks ago - Revelation Biosciences Inc. Announces Exercise of Warrants for $9.6 Million in Gross Proceeds - Accesswire
7 weeks ago - Revelation Biosciences Announces Special Webcast to Review Positive Top-line Clinical Data - Accesswire
7 weeks ago - Reminder - Webcast/Conference Call to Discuss Fantastic PRIME Phase 1b Top-line Data - Accesswire
7 weeks ago - Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study - Accesswire
2 months ago - Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2025 - Business Wire
3 months ago - Revelation Biosciences, Inc. Congratulates Its Former Chairman of the Board, George Tidmarsh, on His Appointment as the Head of the FDA Center for Drug Evaluation and Research - Business Wire